| Robert Orin Hoffman, MD | |
|
100 N Medical Dr, 3650, Salt Lake City, UT 84113-1103 | |
| (801) 588-2000 | |
| Not Available |
| Full Name | Robert Orin Hoffman |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 43 Years |
| Location | 100 N Medical Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992895593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 174983-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Pediatric Services | 0547552473 | 62 |
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, published three new blog posts last week examining issues discussed at the XIX International AIDS Conference (AIDS 2012).
Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
| Entity Name | Department Of Ophthalmology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851327415 PECOS PAC ID: 6507859899 Enrollment ID: O20040405000187 |
News Archive
Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, published three new blog posts last week examining issues discussed at the XIX International AIDS Conference (AIDS 2012).
Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, published three new blog posts last week examining issues discussed at the XIX International AIDS Conference (AIDS 2012).
Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
| Entity Name | University Of Utah Pediatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, published three new blog posts last week examining issues discussed at the XIX International AIDS Conference (AIDS 2012).
Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Orin Hoffman, MD 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (801) 581-3195 | Robert Orin Hoffman, MD 100 N Medical Dr, 3650, Salt Lake City, UT 84113-1103 Ph: (801) 588-2000 |
News Archive
Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, published three new blog posts last week examining issues discussed at the XIX International AIDS Conference (AIDS 2012).
Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.
eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
› Verified 9 days ago
Douglas P Marx, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4400 S 700 E Ste 130, Salt Lake City, UT 84107 Phone: 801-264-4420 Fax: 801-266-0604 | |
Dr. Eileen Hwang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 65 S Mario Capecchi Dr, Salt Lake City, UT 84132 Phone: 801-581-2352 | |
Paul S. Bernstein, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 65 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2352 | |
Dr. Francis John Wapner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1250 E 3900 S, #310, Salt Lake City, UT 84124 Phone: 801-263-2020 Fax: 801-263-2229 | |
Dr. James G Howard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5169 Cottonwood St Ste 630, Salt Lake City, UT 84107 Phone: 801-312-2020 Fax: 801-312-2022 | |
Marielle Payne Young, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 65 Mario Capecchi Dr, Salt Lake City, UT 84132 Phone: 801-581-2352 | |
Dr. Rachel S Benator, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1025 E 3300 S, Ste B, Salt Lake City, UT 84106 Phone: 801-281-2020 Fax: 801-487-3689 |